Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tylenol ad inquiry

This article was originally published in The Tan Sheet

Executive Summary

Children's Tylenol ad that aired during a Cartoon Network Saturday morning broadcast came to the attention of the Children's Advertising Review Unit (CARU) of the Council of Better Business Bureaus during routine ad monitoring. McNeil said its targeted audience is mothers aged 25 to 49, not children under the age of 12, and "warranted that it was taking measures to help ensure that the spot does not air in the future during programming directed at young children," according to CARU. McNeil recently launched a new print and television campaign in support of Tylenol products (1"The Tan Sheet" April 5, 2004, p. 7)...

You may also be interested in...



McNeil Campaign Advocates Tylenol For Low-Dose Aspirin Users

McNeil Consumer & Specialty Pharmaceuticals is running an ad campaign leveraging research indicating a potential risk in concomitant aspirin and nonsteroidal anti-inflammatory drug use

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096729

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel